NCT06146010 Non Interventional German Leptomeningeal Disease Register
| NCT ID | NCT06146010 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Tuebingen |
| Condition | Meningeal Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-06-26 |
| Primary Completion | 2029-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-06-26 with a primary completion date of 2029-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The planned multicenter register is intended to create a database in the form of a cancer register on the incidence and course of disease in Germany of leptomeningeal disease, the therapeutic measures administered in the real world and the complications.
Eligibility Criteria
Inclusion Criteria: * Patients with leptomeningeal disease * Written consent of the patient or legal guardian. * Capacity to give consent or legal guardianship * Age ≥ 18 years Exclusion Criteria: * Lack of informed consent from the patient * Lack of capacity to consent on the part of the person concerned or lack of legal guardianship * Age \< 18 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06146010 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Meningeal Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06146010 currently recruiting?
Yes, NCT06146010 is actively recruiting participants. Contact the research team at Tabatabai.Office@med.uni-tuebingen.de for enrollment information.
Where is the NCT06146010 trial being conducted?
This trial is being conducted at Bonn, Germany, Mannheim, Germany, München, Germany, Münster, Germany and 3 additional locations.
Who is sponsoring the NCT06146010 clinical trial?
NCT06146010 is sponsored by University Hospital Tuebingen. The trial plans to enroll 50 participants.